Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

VAXART, INC - 41 Year Stock Price History | VXRT

Historical daily share price chart and data for VAXART, INC since 1984 adjusted for splits and dividends. The latest closing stock price for VAXART, INC as of May 28, 2025 is 0.45.
  • The all-time high VAXART, INC stock closing price was 1045.98 on May 05, 2004.
  • The VAXART, INC 52-week high stock price is 1.07, which is 137.8% above the current share price.
  • The VAXART, INC 52-week low stock price is 0.28, which is 37.8% below the current share price.
  • The average VAXART, INC stock price for the last 52 weeks is 0.65.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
VAXART, INC Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 0.5437 0.7187 0.9403 0.3065 0.4500 -32.03%
2024 0.8316 0.6090 1.4100 0.5252 0.6621 15.59%
2023 0.8267 0.9357 1.4100 0.5698 0.5728 -40.39%
2022 3.4079 6.6400 6.6400 0.7497 0.9609 -84.67%
2021 7.4321 6.3300 23.3300 5.0600 6.2700 9.81%
2020 4.8889 0.3604 16.9700 0.3362 5.7100 1529.10%
2019 0.9205 1.9800 2.3400 0.2763 0.3505 -81.36%
2018 4.2552 5.9070 9.0475 1.8800 1.8800 -69.82%
2017 7.4883 13.3100 15.4000 4.8565 6.2293 -53.96%
2016 16.3745 21.7800 23.9800 12.6500 13.5300 -36.60%
2015 24.5378 27.0600 31.3500 19.5800 21.3400 -13.39%
2014 39.2071 50.3800 76.7800 23.6500 24.6400 -46.54%
2013 43.1986 43.4500 48.8400 34.1000 46.0900 5.01%
2012 94.4096 111.9430 116.0890 42.9000 43.8900 -60.58%
2011 226.3037 347.6740 347.6740 93.5816 111.3500 -67.53%
2010 316.1959 299.6980 368.9960 278.9680 342.9350 18.16%
2009 210.3072 213.8160 306.8060 131.4880 290.2220 46.27%
2008 244.8448 224.4770 357.7420 177.6870 198.4170 -7.20%
2007 273.7648 393.2800 393.2800 184.7940 213.8160 -46.76%
2006 329.0837 203.7470 434.1480 203.1550 401.5720 100.59%
2005 672.8014 860.0030 937.0010 183.6090 200.1940 -76.93%
2004 843.5980 777.6750 1045.9800 518.8450 867.7030 15.26%
2003 448.3333 370.1810 753.9840 299.1060 752.7990 105.00%
2002 366.5382 602.9500 603.5420 213.2240 367.2190 -39.92%
2001 395.3314 273.9340 651.5180 251.7230 611.2420 123.13%
2000 383.9705 281.3370 651.5180 192.4940 273.9340 0.00%
1999 218.3074 162.8790 355.3730 144.3700 273.9340 72.09%
1998 184.4513 205.4500 277.6350 66.6325 159.1780 -21.10%
1997 416.5665 540.4640 732.9580 196.1960 201.7480 -61.07%
1996 642.1066 636.7110 858.8190 444.2170 518.2530 -18.60%
1995 528.3666 422.0060 681.1320 377.5840 636.7110 43.33%
1994 377.0517 192.4940 496.0420 181.3890 444.2170 126.41%
1993 168.1469 162.8790 214.7050 122.1600 196.1960 17.78%
1992 208.9480 203.5990 266.5300 162.8790 166.5810 -15.09%
1991 98.6685 59.2289 255.4250 55.5271 196.1960 253.33%
1990 70.9118 49.9744 103.6510 49.9744 55.5271 0.00%
1989 52.3361 49.9744 68.4834 40.7199 55.5271 11.11%
1988 66.9617 51.8253 88.8433 44.4217 49.9744 -20.59%
1987 140.0223 83.3350 336.8640 44.4217 62.9307 -24.48%
1986 102.2159 61.1242 153.6250 61.1242 83.3350 36.34%
1985 64.5615 62.9307 107.3520 40.7199 61.1242 -2.87%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.105B $0.029B
Vaxart, Inc. is a clinical-stage company developing a range of oral recombinant vaccines based on its proprietary delivery platform. The company's vaccines are administered using convenient room temperature-stable tablets that can be stored and shipped without refrigeration and eliminate risk of needle-stick injury. Its development programs are oral tablet vaccines designed to protect against norovirus, seasonal influenza and respiratory syncytial virus, as well as a therapeutic vaccine for human papillomavirus. Vaxart, Inc., formerly known as Aviragen Therapeutics, is based in South San Francisco, United States.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $87.311B 32.75
Zoetis (ZTS) United States $74.020B 27.62
Daiichi Sankyo, - (DSNKY) Japan $51.315B 26.11
Takeda Pharmaceutical (TAK) Japan $46.678B 9.28
Sandoz Group AG (SDZNY) Switzerland $21.655B 0.00
Summit Therapeutics (SMMT) United States $19.042B 0.00
Merck (MKKGY) Germany $17.125B 12.55
United Therapeutics (UTHR) United States $14.201B 12.56
Shionogi (SGIOY) Japan $14.121B 14.15
Neurocrine Biosciences (NBIX) United States $12.137B 41.57
IPSEN (IPSEY) France $9.821B 0.00
Orion OYJ (ORINY) Finland $9.323B 25.21
Corcept Therapeutics (CORT) United States $8.145B 66.22
Stevanato Group S.p.A (STVN) Italy $6.917B 42.30
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Madrigal Pharmaceuticals (MDGL) United States $6.030B 0.00
Grifols, S.A (GRFS) Spain $5.659B 0.00
Ionis Pharmaceuticals (IONS) United States $5.303B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.875B 14.83
Soleno Therapeutics (SLNO) United States $3.843B 0.00
Catalyst Pharmaceuticals (CPRX) United States $3.030B 10.61
Hypermarcas (HYPMY) Brazil $2.873B 18.90
Crinetics Pharmaceuticals (CRNX) United States $2.762B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.285B 12.36
BioCryst Pharmaceuticals (BCRX) United States $2.258B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.910B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.785B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.705B 0.00
Indivior (INDV) United States $1.630B 6.92
Evotec AG (EVO) Germany $1.518B 0.00
ARS Pharmaceuticals (SPRY) United States $1.436B 0.00
Guardian Pharmacy Services (GRDN) United States $1.401B 0.00
Dyne Therapeutics (DYN) United States $1.330B 0.00
Ocular Therapeutix (OCUL) United States $1.106B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.101B 22.03
Harrow (HROW) United States $0.966B 0.00
Ardelyx (ARDX) United States $0.950B 0.00
Collegium Pharmaceutical (COLL) United States $0.947B 5.11
Avadel Pharmaceuticals (AVDL) Ireland $0.876B 0.00
Enliven Therapeutics (ELVN) United States $0.785B 0.00
Cronos Group (CRON) Canada $0.771B 0.00
Akebia Therapeutics (AKBA) United States $0.767B 0.00
Xeris Biopharma Holdings (XERS) United States $0.755B 0.00
AleAnna (ANNA) United States $0.675B 0.00
Elite Pharmaceuticals (ELTP) United States $0.568B 0.00
USANA Health Sciences (USNA) United States $0.566B 12.30
KalVista Pharmaceuticals (KALV) United States $0.558B 0.00
Xencor (XNCR) United States $0.552B 0.00
Regulus Therapeutics (RGLS) United States $0.548B 0.00
Bioventus (BVS) United States $0.536B 13.60
Relay Therapeutics (RLAY) United States $0.489B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.464B 0.00
Zevra Therapeutics (ZVRA) United States $0.462B 0.00
Altimmune (ALT) United States $0.447B 0.00
Siga Technologies (SIGA) United States $0.434B 9.07
Oruka Therapeutics (ORKA) United States $0.428B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.421B 0.00
CytoDyn (CYDY) United States $0.406B 0.00
Tourmaline Bio (TRML) United States $0.398B 0.00
Verve Therapeutics (VERV) United States $0.382B 0.00
Organogenesis (ORGO) United States $0.377B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.351B 9.48
Savara (SVRA) United States $0.335B 0.00
Heron Therapeutics (HRTX) United States $0.288B 0.00
Nature's Sunshine Products (NATR) United States $0.272B 25.14
Tonix Pharmaceuticals Holding (TNXP) United States $0.271B 0.00
Aquestive Therapeutics (AQST) United States $0.253B 0.00
MediWound (MDWD) Israel $0.230B 0.00
ProKidney (PROK) United States $0.214B 0.00
Journey Medical (DERM) United States $0.181B 0.00
Wellgistics Health (WGRX) United States $0.180B 0.00
Nanobiotix S.A (NBTX) France $0.180B 0.00
Esperion Therapeutics (ESPR) United States $0.163B 0.00
OmniAb (OABI) United States $0.162B 0.00
Avita Medical (RCEL) United States $0.160B 0.00
Profound Medical (PROF) Canada $0.159B 0.00
4D Molecular Therapeutics (FDMT) United States $0.158B 0.00
Aclaris Therapeutics (ACRS) United States $0.138B 0.00
Liminatus Pharma (LIMN) $0.132B 0.00
Aldeyra Therapeutics (ALDX) United States $0.132B 0.00
Inhibikase Therapeutics (IKT) United States $0.132B 0.00
Nektar Therapeutics (NKTR) United States $0.126B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.124B 0.00
Protara Therapeutics (TARA) United States $0.122B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
Lyell Immunopharma (LYEL) United States $0.121B 0.00
Korro Bio (KRRO) United States $0.120B 0.00
Larimar Therapeutics (LRMR) United States $0.117B 0.00
Achieve Life Sciences (ACHV) Canada $0.110B 0.00
Cassava Sciences (SAVA) United States $0.103B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.101B 0.00
OptiNose (OPTN) United States $0.097B 0.00
Cardiol Therapeutics (CRDL) Canada $0.096B 0.00
Fractyl Health (GUTS) United States $0.096B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.090B 0.00
Lexeo Therapeutics (LXEO) United States $0.090B 0.00
Inotiv (NOTV) United States $0.088B 0.00
Arch Biopartners (ACHFF) Canada $0.084B 0.00
Galectin Therapeutics (GALT) United States $0.083B 0.00
Champions Oncology (CSBR) United States $0.083B 13.61
Cumberland Pharmaceuticals (CPIX) United States $0.080B 59.33
Pyxis Oncology (PYXS) United States $0.077B 0.00
ESSA Pharma (EPIX) Canada $0.071B 0.00
Unicycive Therapeutics (UNCY) United States $0.071B 0.00
Dominari Holdings (DOMH) United States $0.069B 0.00
Vivani Medical (VANI) United States $0.068B 0.00
Nutriband (NTRB) United States $0.067B 0.00
Surrozen (SRZN) United States $0.066B 0.00
Assertio Holdings (ASRT) United States $0.065B 0.00
Telomir Pharmaceuticals (TELO) United States $0.063B 0.00
Metagenomi (MGX) United States $0.062B 0.00
Context Therapeutics (CNTX) United States $0.061B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.053B 0.00
Gain Therapeutics (GANX) United States $0.052B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.051B 0.00
Century Therapeutics (IPSC) United States $0.048B 0.00
PMV Pharmaceuticals (PMVP) United States $0.047B 0.00
Mural Oncology (MURA) Ireland $0.045B 0.00
Prelude Therapeutics (PRLD) United States $0.045B 0.00
NRx Pharmaceuticals (NRXP) United States $0.045B 0.00
Karyopharm Therapeutics (KPTI) United States $0.039B 0.00
Avalo Therapeutics (AVTX) United States $0.039B 0.00
Iterum Therapeutics (ITRM) Ireland $0.038B 0.00
ElectroCore (ECOR) United States $0.036B 0.00
Acrivon Therapeutics (ACRV) United States $0.034B 0.00
FibroGen (FGEN) United States $0.032B 0.00
Rafael Holdings (RFL) United States $0.032B 0.00
SCYNEXIS (SCYX) United States $0.028B 0.00
PolyPid (PYPD) Israel $0.026B 0.00
China SXT Pharmaceuticals (SXTC) China $0.024B 0.00
Enlivex Therapeutics (ENLV) Israel $0.024B 0.00
CASI Pharmaceuticals (CASI) China $0.023B 0.00
Tempest Therapeutics (TPST) United States $0.023B 0.00
Relmada Therapeutics (RLMD) United States $0.022B 0.00
Jupiter Neurosciences (JUNS) United States $0.021B 0.00
Natural Alternatives (NAII) United States $0.020B 0.00
BioVie (BIVI) United States $0.019B 0.00
Lipocine (LPCN) United States $0.019B 0.00
Mannatech (MTEX) United States $0.018B 0.00
TherapeuticsMD (TXMD) United States $0.017B 0.00
DURECT (DRRX) United States $0.016B 0.00
SHINECO (SISI) China $0.015B 0.00
VYNE Therapeutics (VYNE) United States $0.015B 0.00
ProPhase Labs (PRPH) United States $0.015B 0.00
Ernexa Therapeutics (ERNA) United States $0.015B 0.00
GlycoMimetics (GLYC) United States $0.015B 0.00
MEI Pharma (MEIP) United States $0.014B 0.00
Cosmos Health (COSM) United States $0.013B 0.00
Vivos Therapeutics (VVOS) United States $0.013B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.013B 0.00
Ainos (AIMD) United States $0.013B 0.00
BioLineRx (BLRX) Israel $0.012B 0.00
Scienture Holdings (SCNX) United States $0.012B 0.00
Minerva Neurosciences (NERV) United States $0.010B 1.82
Talphera (TLPH) United States $0.010B 0.00
Mangoceuticals (MGRX) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Phio Pharmaceuticals (PHIO) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Incannex Healthcare (IXHL) Australia $0.008B 0.00
Carisma Therapeutics (CARM) United States $0.008B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.007B 0.00
Citius Pharmaceuticals (CTXR) United States $0.007B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Klotho Neurosciences (KLTO) United States $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
Lyra Therapeutics (LYRA) United States $0.006B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.006B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Indaptus Therapeutics (INDP) United States $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Plus Therapeutics (PSTV) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
PainReform (PRFX) Israel $0.004B 0.00
Aditxt (ADTX) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.003B 0.00
Conduit Pharmaceuticals (CDT) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00